In the context of precision medicine, PAD2 shows different expression patterns depending on the type of cancer—it is high in tumor tissues and blood of patients with breast, liver, stomach, and cervical cancer [138,139], but appears to act as a tumor suppressor in colorectal cancer [140]. This evidence concerns the gene PADI2 and neoplasm.